# EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial)

> **NCT05151172** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Dr. Michael D Hill** · enrollment: 530 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DEVICE:** endovascular thrombectomy (EVT)
- **OTHER:** Standarad medical care

## Key facts

- **NCT ID:** NCT05151172
- **Lead sponsor:** Dr. Michael D Hill
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-04-15
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-06-30
- **Target enrollment:** 530 (ESTIMATED)
- **Last updated:** 2024-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05151172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05151172, "EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05151172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*